Ashe Andrew D. — SEC Form 4 filings
SEC reporting owner CIK 1573163. 5 Form 4 filings on record with FilingPulse; latest filed 2025-07-28.
Transaction summary — filings shown
Covers all 5 filings on record, filed 2024-02-16 to 2025-07-28. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 1 leg across 1 filing — 76,000 shares, $475,760 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 1 leg across 1 filing — 2,681 shares, $11,126 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 14.
- Largest priced transaction: purchase of 76,000 shares @ $6.26 ($475,760) in Verve Therapeutics, Inc., filed 2024-05-15.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Verve Therapeutics, Inc. (VERV) | See Remarks | 5 | 1 leg · 76,000 sh · $475,760 | 1 leg · 2,681 sh · $11,126 | 14 |
Form 4 filings — Ashe Andrew D.
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2025-07-28 | 4 | Verve Therapeutics, Inc. (VERV) | Code (U): 348,828 · Disposition to issuer (D): 225,000 (derivative) · Disposition to issuer (D): 40,000 (derivative) · Disposition to issuer (D): 27,000 (derivative) · Disposition to issuer (D): 107,997 (derivative) · Disposition to issuer (D): 153,278 (derivative) · +2 more | EDGAR |
| 2025-04-03 | 4 | Verve Therapeutics, Inc. (VERV) | Option exercise (M): 9,000 · Sale (S): 2,681 @ $4.15 · Option exercise (M): 9,000 (derivative) @ $0 | EDGAR |
| 2025-01-10 | 4 | Verve Therapeutics, Inc. (VERV) | Grant/award (A): 225,000 (derivative) @ $0 · Grant/award (A): 40,000 (derivative) @ $0 | EDGAR |
| 2024-05-15 | 4 | Verve Therapeutics, Inc. (VERV) | Purchase (P): 76,000 @ $6.26 | EDGAR |
| 2024-02-16 | 4 | Verve Therapeutics, Inc. (VERV) | Grant/award (A): 150,000 (derivative) @ $0 · Grant/award (A): 36,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1573163 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →